PharmChem Inc
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.
Market Cap & Net Worth: PharmChem Inc (PCHM)
PharmChem Inc (PINK:PCHM) has a market capitalization of $15.11 Million ($15.11 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #43037 globally and #13828 in its home market, demonstrating a 3.81% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PharmChem Inc's stock price $3.27 by its total outstanding shares 4621190 (4.62 Million).
PharmChem Inc Market Cap History: 2015 to 2025
PharmChem Inc's market capitalization history from 2015 to 2025. Data shows growth from $921.00K to $15.11 Million (62.65% CAGR).
PharmChem Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PharmChem Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.35x
PharmChem Inc's market cap is 2.35 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
10.38x
PharmChem Inc's market cap is 10.38 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.47 Million | $4.17 Million | $1.02 Million | 0.35x | 1.45x |
| 2017 | $3.66 Million | $4.69 Million | $1.18 Million | 0.78x | 3.11x |
| 2018 | $2.19 Million | $5.16 Million | $1.56 Million | 0.42x | 1.40x |
| 2019 | $8.24 Million | $5.54 Million | $1.72 Million | 1.49x | 4.79x |
| 2020 | $14.89 Million | $6.67 Million | $1.96 Million | 2.23x | 7.59x |
| 2021 | $19.72 Million | $6.22 Million | $1.85 Million | 3.17x | 10.65x |
| 2022 | $8.05 Million | $5.84 Million | $870.43K | 1.38x | 9.25x |
| 2023 | $11.18 Million | $6.01 Million | $845.10K | 1.86x | 13.23x |
| 2024 | $14.33 Million | $6.09 Million | $1.38 Million | 2.35x | 10.38x |
Competitor Companies of PCHM by Market Capitalization
Companies near PharmChem Inc in the global market cap rankings as of March 19, 2026.
Key companies related to PharmChem Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
PharmChem Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, PharmChem Inc's market cap moved from $921.00K to $ 15.11 Million, with a yearly change of 62.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $15.11 Million | +5.48% |
| 2024 | $14.33 Million | +28.13% |
| 2023 | $11.18 Million | +38.93% |
| 2022 | $8.05 Million | -59.18% |
| 2021 | $19.72 Million | +32.44% |
| 2020 | $14.89 Million | +80.76% |
| 2019 | $8.24 Million | +276.13% |
| 2018 | $2.19 Million | -40.21% |
| 2017 | $3.66 Million | +148.71% |
| 2016 | $1.47 Million | +59.86% |
| 2015 | $921.00K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of PharmChem Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.11 Million USD |
| MoneyControl | $15.11 Million USD |
| MarketWatch | $15.11 Million USD |
| marketcap.company | $15.11 Million USD |
| Reuters | $15.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.